Literature DB >> 7182013

Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow.

Z Ben-Ishay, G Prindull, S Sharon.   

Abstract

This study deals with murine marrow stromal cells (MSC) during hematopoietic regeneration. Regenerative marrow was induced in infant mice by two consecutive i. p. injections of hydroxyurea (HU) (2 X 1,000 mg/kg) which kill most cells in DNA synthesis. Two days later the marrow becomes enriched in pluripotent stem cells (CFU-S) and committed progenitors. It was found that fibroblastoid colony-forming-units (CFU-F) become concentrated approximately four fold above controls and give rise to significantly larger fibroblastoid colonies than CFU-F in control marrow. In split-phase semisolid agar cultures, i. e. adherent cells of HU-treated marrow (in under layers) and normal bone marrow cells (in upper layers), inhibition of G/M colonies in the upper layer in observed. In control split-phase cultures of both under layers and upper layers of normal bone marrow, CFU-C inhibition is by far less pronounced. In liquid cultures, pre-established adherent layers of HU-treated marrow have a stimulatory effect on normal marrow CFU-C. It is concluded that during increased demand for pluripotent stem cells and progenitors, such as after HU administration, marrow stromal cells and possibly other adherent cells produce inhibitory factor(s) of CFU-C differentiation. The inhibitory activity possibly is an effective mechanism for stem cell pool preservation. The differing effect of adherent cells of HU-treated marrow on CFU-C in liquid and in semi-solid medium suggests production of two different factors with opposing influences on CFU-C, depending upon the culture conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7182013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  1 in total

1.  Cumulative bone marrow stromal damage caused by X-irradiation and cytosine-arabinoside in leukemic mice.

Authors:  Z Ben-Ishay; G Prindull; S Yankelev; S Sharon
Journal:  Med Oncol Tumor Pharmacother       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.